Eupraxia Pharmaceuticals (EPRX) Stock Chart & Stock Price History $4.31 -0.04 (-0.92%) Closing price 03:59 PM EasternExtended Trading$4.31 0.00 (0.00%) As of 05:19 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Eupraxia Pharmaceuticals Stock Price Performance The Eupraxia Pharmaceuticals (EPRX) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 65.13%, with a year-to-date return of 35.96%. In the past month, the stock has increased 11.37%, reflecting recent market activity. As of the latest close, Eupraxia Pharmaceuticals traded at $4.35 with a market cap of $156.43 million and volume of 3,972 shares. Receive EPRX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Eupraxia Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-0.23%1 Month Performance+11.37%3 Month Performance+21.75%Year-To-Date Performance+35.96%1 Year Performance+65.13% EPRX Stock Chart for Wednesday, June, 25, 2025 EPRX Chart by TradingView Eupraxia Pharmaceuticals Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization06/24/2025$4.38$4.35-0.68%$4.41$4.333,972 shs$156.43 million06/23/2025$4.32$4.38+1.39%$4.41$4.1915,007 shs$157.49 million06/20/2025$4.24$4.32+1.89%$4.49$4.2210,162 shs$155.35 million06/19/2025$4.24$4.24$4.33$4.224,922 shs$152.47 million06/18/2025$4.27$4.24-0.70%$4.33$4.224,922 shs$152.46 million06/17/2025$4.17$4.27+2.40%$4.36$4.1222,495 shs$153.54 million06/16/2025$3.86$4.17+8.03%$4.20$3.9410,162 shs$149.94 million06/13/2025$3.88$3.86-0.52%$3.95$3.854,408 shs$138.79 million06/12/2025$3.93$3.88-1.27%$3.96$3.8813,527 shs$139.09 million06/11/2025$3.98$3.93-1.26%$4.00$3.8816,784 shs$140.89 million Get the Latest News and Ratings for EPRX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Eupraxia Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 06/10/2025$3.97$3.98+0.25%$3.99$3.898,296 shs$142.68 million06/09/2025$3.94$3.97+0.89%$4.01$3.8520,634 shs$142.32 million06/06/2025$3.94$3.94-0.13%$3.95$3.9011,001 shs$141.07 million06/05/2025$3.97$3.94-0.76%$3.94$3.899,469 shs$141.25 million06/04/2025$4.07$3.97-2.34%$4.09$3.97798 shs$142.32 million06/03/2025$3.94$4.07+3.17%$4.09$3.8811,276 shs$145.73 million06/02/2025$3.93$3.94+0.25%$3.95$3.8523,072 shs$141.25 million05/30/2025$3.93$3.93$3.93$3.827,576 shs$140.89 million05/29/2025$3.87$3.93+1.55%$3.96$3.8433,929 shs$140.89 million05/28/2025$3.86$3.87+0.26%$3.95$3.8528,292 shs$138.74 million05/27/2025$3.87$3.86-0.26%$3.92$3.8534,225 shs$138.38 million05/26/2025$3.87$3.87$3.87$3.6716,561 shs$138.74 million Related Companies Urogen Pharma Stock Chart Tyra Biosciences Stock Chart Relay Therapeutics Stock Chart Keros Therapeutics Stock Chart Verve Therapeutics Stock Chart Autolus Therapeutics Stock Chart Taysha Gene Therapies Stock Chart Maravai LifeSciences Stock Chart Mind Medicine (MindMed) Stock Chart Arvinas Stock Chart Receive EPRX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Eupraxia Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:EPRX) was last updated on 6/25/2025 by MarketBeat.com Staff From Our PartnersElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredCrypto Is Pumping Again – Now Comes the Real OpportunityThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredTrump’s true trade war strategyThe media and financial pundits are all misreading Trump’s actions. They think Trump wants to make Canada t...Porter & Company | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Eupraxia Pharmaceuticals Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Eupraxia Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy EPRX Stock Free EPRX Stock Alerts